Cargando…

Acute Myeloid Leukemia Expresses a Specific Group of Olfactory Receptors

SIMPLE SUMMARY: Acute myeloid leukemia (AML) is a type of cancer that affects blood cells and is the most common type of acute leukemia in adults. Despite advances in treatment, many patients with AML still face poor outcomes, including a high risk of relapse. Therefore, new ways to treat AML are ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guardia, Gabriela D. A., Naressi, Rafaella G., Buzzato, Vanessa C., da Costa, Juliana B., Zalcberg, Ilana, Ramires, Jordana, Malnic, Bettina, Gutiyama, Luciana M., Galante, Pedro A. F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296317/ https://www.ncbi.nlm.nih.gov/pubmed/37370684 http://dx.doi.org/10.3390/cancers15123073

Ejemplares similares

Odor coding in the mammalian olfactory epithelium
por: Kurian, Smija M., et al.
Publicado: (2021)

Familial Myelodysplastic/Acute Leukemia Syndromes—Myeloid Neoplasms with Germline Predisposition
por: Baptista, Renata Lyrio Rafael, et al.
Publicado: (2017)

Myeloid Neoplasias: What Molecular Analyses Are Telling Us
por: Gutiyama, Luciana M., et al.
Publicado: (2012)

Imatinib resistance: a review of alternative inhibitors in chronic myeloid leukemia
por: Bitencourt, Roberta, et al.
Publicado: (2011)

Depletion of Ric-8B leads to reduced mTORC2 activity
por: Nagai, Maíra H., et al.
Publicado: (2020)

Identification of agonists for a group of human odorant receptors
por: Gonzalez-Kristeller, Daniela C., et al.
Publicado: (2015)

Genome-Wide Detection of Serpentine Receptor-Like Proteins in Malaria Parasites
por: Madeira, Luciana, et al.
Publicado: (2008)

Is the BCR-ABL/GUSB transcript level at diagnosis an early predictive marker for chronic myeloid leukemia patients treated with imatinib?
por: Bonecker, Simone, et al.
Publicado: (2015)

The significance of major and stable molecular responses in chronic myeloid leukemia in the tyrosine kinase inhibitor era
por: Renault, Ilana Zalcberg, et al.
Publicado: (2011)

Uncovering the mouse olfactory long non-coding transcriptome with a novel machine-learning model
por: Camargo, Antonio P, et al.
Publicado: (2019)

Myeloid malignancies‐related somatic mutations in aging individuals
por: Coutinho, Diego F., et al.
Publicado: (2019)

Identification of the MYST3-CREBBP fusion gene in infants with acute myeloid leukemia and hemophagocytosis
por: Andrade, Francianne Gomes, et al.
Publicado: (2016)

Genetic Alterations in Essential Thrombocythemia Progression to Acute Myeloid Leukemia: A Case Series and Review of the Literature
por: Ayres-Silva, Jackline P., et al.
Publicado: (2018)

Topical Dexamethasone Administration Impairs Protein Synthesis and Neuronal Regeneration in the Olfactory Epithelium
por: Crisafulli, Umberto, et al.
Publicado: (2018)

Common Promoter Elements in Odorant and Vomeronasal Receptor Genes
por: Michaloski, Jussara S., et al.
Publicado: (2011)

CD36 is expressed in a defined subpopulation of neurons in the olfactory epithelium
por: Xavier, André Machado, et al.
Publicado: (2016)

Olfactory Dysfunction in Frontline Health Care Professionals During COVID-19 Pandemic in Brazil
por: Sbrana, Mariana Ferreira, et al.
Publicado: (2021)

Multidisciplinary diagnostics of chronic lymphocytic leukemia: European Research Initiative on CLL - ERIC recommendations
por: Zalcberg, Ilana, et al.
Publicado: (2020)

Azacitidine-Induced Pneumonitis in a Patient With Acute Myeloid Leukemia and Hyperleukocytosis
por: Litvin, Rafaella, et al.
Publicado: (2022)

Molecular measurement of BCR-ABL transcript variations in chronic myeloid leukemia patients in cytogenetic remission
por: Serpa, Mariana, et al.
Publicado: (2010)

Comment on: “Validation of interphase fluorescence in situ hybridization (iFISH) of CD138 positive cells in multiple myeloma”()
por: Zalcberg Renault, Ilana
Publicado: (2016)

Detection of somatic TP53 mutations and 17p deletions in patients with chronic lymphocytic leukemia: a review of the current methods
por: Chauffaille, Maria de Lourdes L.F., et al.
Publicado: (2020)

Emerging Epigenetic Therapeutic Targets in Acute Myeloid Leukemia
por: Wingelhofer, Bettina, et al.
Publicado: (2019)

Inclusion of molecular monitoring (BCR-ABL1) in the treatment of chronic myeloid leukemia in the Brazilian Public Health System (SUS): an urgent need for treatment management
por: Boquimpani, Carla Maria, et al.
Publicado: (2021)

Isolated Central Nervous System Relapse in Chronic Myeloid Leukemia
por: Gomez, Juliana, et al.
Publicado: (2015)

Successful Outcomes of Children Simultaneously Diagnosed with Acute Myeloid Leukemia and Covid-19: The Role of a Mild Chemotherapeutic Induction Regimen
por: Lins, Mecneide Mendes, et al.
Publicado: (2020)

Proteomic Characterization of Acute Myeloid Leukemia for Precision Medicine
por: Casado, Pedro, et al.
Publicado: (2023)

Chronic myeloid leukemia versus acute myeloid leukemia in patients with retinoblastoma
por: Leahey, Ann-Marie, et al.
Publicado: (2021)

Severe electrolyte derangements from lysozymuria in acute myeloid leukemia
por: Pérez‐Pinzón, Juliana, et al.
Publicado: (2022)

Real-world Imatinib Mesylate Treatment in Patients with Chronic Myeloid Leukemia: The Importance of Molecular Monitoring and the Early Molecular Response
por: Ferreira, Amanda Pifano Soares, et al.
Publicado: (2023)

Acute Myeloid Leukemia
Publicado: (2019)

Acute myeloid leukemia
por: Haferlach, Torsten
Publicado: (2019)

Chronic myeloid leukemia
por: Hantschel, Oliver
Publicado: (2019)

Acute myeloid leukemia
por: Ossenkoppele, Gert
Publicado: (2018)

Chronic myeloid leukemia
por: Sauβele, Susanne
Publicado: (2018)

Molecular evidence for the clonal origin of blast crisis in chronic myeloid leukaemia.
por: Zalcberg, J. R., et al.
Publicado: (1986)

Harnessing Macrophages through the Blockage of CD47: Implications for Acute Myeloid Leukemia
por: Melo Garcia, Luciana, et al.
Publicado: (2021)

Correction to: Real‑world imatinib mesylate treatment in patients with chronic myeloid leukemia: The importance of molecular monitoring and the early molecular response
por: Ferreira, Amanda Pifano Soares, et al.
Publicado: (2023)

Brazilian chronic myeloid leukemia working group recommendations for discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia in clinical practice
por: Boquimpani, Carla, et al.
Publicado: (2022)

Successful Pregnancy and Delivery in a Patient with Chronic Myeloid Leukemia while on Dasatinib Therapy
por: Conchon, Monika, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_2le8tntou28jothop8om6intid